- Home
- KREF vs SIGA Comparison
KREF vs SIGA Comparison
Compare KREF & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KREF
- SIGA
- Stock Information
- Founded
- KREF 2014
- SIGA 1995
- Country
- KREF United States
- SIGA United States
- Employees
- KREF N/A
- SIGA N/A
- Industry
- KREF Real Estate Investment Trusts
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- KREF Real Estate
- SIGA Health Care
- Exchange
- KREF Nasdaq
- SIGA Nasdaq
- Market Cap
- KREF 623.9M
- SIGA 515.1M
- IPO Year
- KREF 2017
- SIGA 1997
- Fundamental
- Price
- KREF $8.67
- SIGA $8.37
- Analyst Decision
- KREF Buy
- SIGA
- Analyst Count
- KREF 6
- SIGA 0
- Target Price
- KREF $12.04
- SIGA N/A
- AVG Volume (30 Days)
- KREF 854.1K
- SIGA 496.1K
- Earning Date
- KREF 10-22-2025
- SIGA 11-06-2025
- Dividend Yield
- KREF 11.49%
- SIGA 7.24%
- EPS Growth
- KREF N/A
- SIGA N/A
- EPS
- KREF N/A
- SIGA 1.14
- Revenue
- KREF $40,393,000.00
- SIGA $179,639,422.00
- Revenue This Year
- KREF $23.74
- SIGA N/A
- Revenue Next Year
- KREF N/A
- SIGA $115.06
- P/E Ratio
- KREF N/A
- SIGA $7.28
- Revenue Growth
- KREF N/A
- SIGA 3.86
- 52 Week Low
- KREF $8.28
- SIGA $4.95
- 52 Week High
- KREF $12.33
- SIGA $9.62
- Technical
- Relative Strength Index (RSI)
- KREF 29.44
- SIGA 44.69
- Support Level
- KREF $8.87
- SIGA $8.90
- Resistance Level
- KREF $9.13
- SIGA $9.29
- Average True Range (ATR)
- KREF 0.20
- SIGA 0.35
- MACD
- KREF -0.09
- SIGA -0.11
- Stochastic Oscillator
- KREF 5.73
- SIGA 15.38
About KREF KKR Real Estate Finance Trust Inc.
KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.